Navigation Links
InspireMD Announces First Quarter 2012 Financial Results
Date:5/8/2012

perty, plant and equipment, net of accumulated depreciation and amortization

465

420Other non-current assets:Funds in respect of employees rights upon retirement

236

215Deferred issuance costs

25Total other non-current assets

261

215Total assets

$8,527

$10,465 March 31,

December 31,2012

2011LIABILITIES AND EQUITYCurrent liabilities:Current maturities of long-term loans

$-

$94Accounts payable and accruals:Trade

333

814Other

2,858

2,217Advanced payment from customers

192

316Deferred revenues

25Total current liabilities

3,408

3,441Long-term liabilityLiability for employees rights upon retirement

317

270Total long-term liabilities

317

270Commitments and contingent liabilities -Total liabilities

3,725

3,711Equity:Common stock, par value $0.0001 per share; 125,000,000 shares authorized;
68,178,946 shares issued and outstanding at March 31, 2012
and December 31, 2011.

7

7Additional paid-in capital

44,576

43,388Accumulated deficit

(39,781)

(36,641)Total equity

4,802

6,754Total liabilities and equity 

$8,527

$10,465(1) All 2012 financial information is derived from the Company's 2012 unaudited financial statements and all 2011 financial information is derived from the Company's 2011 audited financial statements, as disclosed in the Company's Annual Report on Form 10-K, filed with the Securities and Exchange Commission.

About MGuard™ Coronary StentMGuard™ presents a novel combination of a coronary stent merged with an embolic protection specifically designed for acute MI patients. The embolic protection is comprised of an ultra-thin polymer micron net that wraps the stent. The MGuard͐
'/>"/>

SOURCE InspireMD, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients
2. For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
3. InspireMD Becomes a Supporting Organization in the Growing Stent for Life Initiative
4. InspireMD Boosts MGuard Production Capacity
5. InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR"
6. InspireMD to Participate in Benchmark Company, LLC 2011 One-On-One Investor Conference
7. InspireMD Increases Geographic Penetration; MGuard Stent is Now Available in India
8. InspireMD Promotes MGuard™ at the EuroPCR 2011 Exhibition and Conference in Paris This Week
9. InspireMD Announces Year-to-Date 2011 Progress
10. InspireMD Broadens Global Distribution Network; Signs Distributor for the Russian Federation
11. Sol J. Barer, Ph.D. Joins InspireMD Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 Decision Resources, one of the world,s leading ... that, over the past 12 months, 25 percent of surveyed ... Germany , Italy , ... ) have been required to change the antiretroviral (ARV) ... to reduce costs. Additionally, more than 40 percent of respondents ...
(Date:6/18/2013)... June 18, 2013 Today, Wall Street ... GILD ), Health Management Associates Inc. (NYSE: ... ), ISIS Pharmaceuticals Inc. (NASDAQ: ISIS ), and ... reports free of charge - including full price targets, industry ... Gilead Sciences, Inc. Research Report On June ...
(Date:6/18/2013)... , June 18, 2013 Apama ... on the development of next-generation atrial fibrillation technologies, ... 8295902 by the US Patent and Trademark Office ... low profile electrode assemblies for use on expandable ... or other surgical procedures. "We are ...
Breaking Medicine Technology:One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6
... 2011 Data presented at the 47th American Society ... of circulating tumor cells (CTC) as a biomarker for ... first randomized, double-blind, placebo controlled Phase III trial to ...  Biomarkers are of scientific interest as, if validated, they ...
... 3, 2011 Civil penalties amounting to $327,073,700 have ... South Carolina versus Ortho-McNeil-Janssen Pharmaceuticals and Johnson & Johnson, ... on June 3 through a written order. John B. ... White, Smith & Coggins, P.C., a Spartanburg-based law firm, ...
Cached Medicine Technology:Late-Breaking ASCO Data Demonstrate Circulating Tumor Cells as Potential Biomarker for Metastatic Prostate Cancer Clinical Trials 2Late-Breaking ASCO Data Demonstrate Circulating Tumor Cells as Potential Biomarker for Metastatic Prostate Cancer Clinical Trials 3Late-Breaking ASCO Data Demonstrate Circulating Tumor Cells as Potential Biomarker for Metastatic Prostate Cancer Clinical Trials 4Record Breaking $327 Million Verdict Announced in Janssen Case 2
(Date:6/18/2013)... Tarrytown, NY (PRWEB) June 18, 2013 ... simply to grow in size. Quite the opposite. ... and audiology practice-with over 140 expertly trained physicians offering ... communities in 40 locations throughout the Greater New York ... the important circumstances are right. And that includes the ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Sun Buick GMC, ... Family Health Services 20th Annual Golf Tournament on Thursday, June ... The hole-in-one prize is a 2013 Buick Verano and will ... gets a hole-in-one on Irem’s 7th hole. , The MFHS ... format is a four person captain and crew team for ...
(Date:6/18/2013)... have a much different and more complex ... of Texas at Dallas have found that exploiting these ... cancer. , In an article published online May 21 ... researchers compared the metabolic characteristics of non-small-cell lung cancer ... patient. , They found that the cancer cells ...
(Date:6/18/2013)... HOUSTON Researchers have discovered and mapped the signaling ... that, if broken, could cut off cancer cell growth ... scientists at The University of Texas MD Anderson Cancer ... (EGFR), a well-known cancer drug target, and MCM7, a ... in the June issue of Cancer Cell . ...
(Date:6/18/2013)... 2013 The Elizabeth Glaser Pediatric AIDS ... the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) ... new milestones in the global effort to eliminate pediatric ... that as of June 2013, one million babies globally ... Since PEPFAR’s inception in 2003, EGPAF has been a ...
Breaking Medicine News(10 mins):Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 2Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 3Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 4Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 5Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 2Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 3
... ... of prime labels with new site enhancements. The site enhancements provide customers with a ... , ... (PRWEB) August 5, 2009 -- My1Stop.com, the commercial printing superstore, launched upgraded prime label ...
... , , , ... healthcare applications and services will grow at a five-year cumulative annual growth ... according to Wireless Healthcare: Analysis & Forecasts ... research firm Parks Associates predicts the push for ...
... of women in the US are recalled for a second ... most women this can be very stressful. However the use ... be associated with a substantial decrease in recall rate, according ... researchers believe that digital breast tomosynthesis depicts the breast tissue ...
... are a woman who dines with a man, chances are you ... woman. That is one of the findings in a study conducted ... online version of the international journal Appetite . Meredith ... found that what a person chooses to eat at lunch or ...
... Forum for People Performance Management and Measurement white paper ... quality , , NAPERVILLE, Ill., Aug. ... billions of dollars each year in new technology and infrastructure to ... be in its people, according to a new white paper published ...
... , , WASHINGTON, Aug. 5 ... latest report on effective emergency management for people with disabilities ... of Emergency Managers, 2009 National Conference on Community ... at the Hyatt Regency Crystal City Hotel, 2799 Jefferson ...
Cached Medicine News:Health News:My1Stop.com Completes Upgrades to Prime Labels Offering and Easy Ordering Page Design 2Health News:Wireless Home Healthcare to be $4 Billion Industry by 2013 2Health News:Wireless Home Healthcare to be $4 Billion Industry by 2013 3Health News:What you eat depends on with whom you eat 2Health News:Happy Employees Lead to Healthier Patients 2Health News:Happy Employees Lead to Healthier Patients 3
... Seat height: Bench high, 26-31". Ergonomic ... "Soft Touch" pnuematic control for easy ... Static-control casters allow easy mobility. Fixed ... Decay (from 5000 Volts to technical ...
Attachments: Clip bar for tubes 10 to 19 mm in diameter Overall Dimension Height IC: 6 (15.2) Overall Dimension Length IC: 18.5 (46.9) Overall Dimension Width IC: 4 (10.2)...
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in....
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in....
Medicine Products: